IRIS - Res&Arch Institutional Research Information System - Research & Archive

CALABRESI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.349
EU - Europa 13.644
AS - Asia 11.346
SA - Sud America 2.711
Continente sconosciuto - Info sul continente non disponibili 1.177
AF - Africa 324
OC - Oceania 17
Totale 49.568
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.601
SG - Singapore 5.236
IT - Italia 2.315
UA - Ucraina 2.306
IE - Irlanda 2.121
BR - Brasile 2.088
RU - Federazione Russa 1.737
CN - Cina 1.498
VN - Vietnam 1.485
SE - Svezia 1.378
HK - Hong Kong 1.308
FR - Francia 958
DE - Germania 862
FI - Finlandia 635
GB - Regno Unito 475
KR - Corea 383
CA - Canada 305
IN - India 232
AR - Argentina 198
BD - Bangladesh 192
TR - Turchia 170
NL - Olanda 143
MX - Messico 126
IQ - Iraq 124
PL - Polonia 115
ID - Indonesia 107
CO - Colombia 99
ZA - Sudafrica 97
EC - Ecuador 94
AT - Austria 86
CH - Svizzera 85
JP - Giappone 85
PK - Pakistan 81
UZ - Uzbekistan 81
VE - Venezuela 76
CZ - Repubblica Ceca 72
RO - Romania 72
SA - Arabia Saudita 59
ES - Italia 55
BE - Belgio 54
CR - Costa Rica 54
CL - Cile 49
MA - Marocco 49
JM - Giamaica 46
PY - Paraguay 35
TT - Trinidad e Tobago 35
MY - Malesia 33
PH - Filippine 33
LT - Lituania 32
GR - Grecia 30
LB - Libano 30
NI - Nicaragua 30
GT - Guatemala 28
DZ - Algeria 27
KE - Kenya 27
PE - Perù 27
HN - Honduras 26
TN - Tunisia 26
EG - Egitto 25
IL - Israele 24
JO - Giordania 24
UY - Uruguay 24
EU - Europa 22
CW - ???statistics.table.value.countryCode.CW??? 19
GP - Guadalupe 19
KZ - Kazakistan 19
SV - El Salvador 19
AZ - Azerbaigian 18
BO - Bolivia 18
AL - Albania 17
PR - Porto Rico 16
AE - Emirati Arabi Uniti 15
ET - Etiopia 15
NP - Nepal 14
AU - Australia 13
DO - Repubblica Dominicana 12
OM - Oman 12
PS - Palestinian Territory 12
KG - Kirghizistan 11
TH - Thailandia 11
PA - Panama 10
BG - Bulgaria 9
EE - Estonia 9
CI - Costa d'Avorio 8
HU - Ungheria 8
RS - Serbia 8
XK - ???statistics.table.value.countryCode.XK??? 8
CG - Congo 7
HR - Croazia 7
SN - Senegal 7
SY - Repubblica araba siriana 7
BA - Bosnia-Erzegovina 6
BB - Barbados 6
BY - Bielorussia 6
DK - Danimarca 6
GE - Georgia 6
PT - Portogallo 6
TW - Taiwan 6
MD - Moldavia 5
ME - Montenegro 5
Totale 48.330
Salva come PNG Salva come JPEG
Città #
Singapore 3.635
Chandler 2.392
Dublin 2.111
San Jose 1.483
Ashburn 1.318
Hong Kong 1.296
Jacksonville 1.149
San Mateo 1.146
Boardman 851
Santa Clara 765
Council Bluffs 665
Dong Ket 648
Moscow 582
Princeton 547
Medford 537
Perugia 519
Altamura 490
Lauterbourg 452
Wilmington 402
Lawrence 389
Seoul 377
Des Moines 370
Beijing 364
Andover 343
Ann Arbor 308
Ho Chi Minh City 285
Los Angeles 257
Munich 216
The Dalles 197
São Paulo 192
Piscataway 173
Hanoi 169
New York 168
Saint Petersburg 147
Milan 116
Dallas 114
Rome 107
Frankfurt am Main 105
Helsinki 101
Phoenix 100
Norwalk 97
Turku 89
San Paolo di Civitate 83
Falls Church 78
Woodbridge 78
Atlanta 77
Tokyo 75
Rio de Janeiro 71
Izmir 70
Montreal 69
Redmond 69
Shanghai 69
Warsaw 68
Brooklyn 65
Chicago 62
Houston 61
Orem 61
Toronto 61
London 55
Denver 54
Brussels 53
Bucharest 53
Stockholm 51
Carrboro 49
Chennai 48
Johannesburg 48
North Bergen 48
Tashkent 48
Dearborn 46
Baghdad 42
San Francisco 41
Naples 40
Columbus 39
San José 39
Belo Horizonte 38
Boston 38
Brno 38
Brasília 36
Buffalo 36
Haiphong 36
Mexico City 36
Nuremberg 34
Amsterdam 32
Bologna 32
Curitiba 32
Redwood City 32
Guayaquil 31
Charlotte 30
Kingston 30
Quito 30
Den Haag 29
Managua 29
Poplar 29
Porto Alegre 29
Manchester 28
Medellín 28
Seattle 28
Da Nang 27
Ankara 25
Campinas 25
Totale 28.461
Salva come PNG Salva come JPEG
Nome #
The validation of an Italian version of the Freezing of Gait Questionnaire 885
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 229
CSF and blood biomarkers for Parkinson's disease 216
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 184
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 174
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 169
Aortic stiffness and pulse wave reflection in young subjects with migraine: A case-control study. 165
Migraine-specific quality of life questionnaire and relapse of medication overuse headache 160
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 159
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 158
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 152
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 151
Brain arteriovenous malformations and seizures: an Italian study. 150
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 148
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression. 146
Cyclic vomiting syndrome, migraine, and epilepsy: a common underlying disorder? 145
Hippocampal epileptogenesis in autoimmune encephalitis 141
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 140
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 137
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 137
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 137
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 135
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 134
A magnetization transfer study of mild and advanced Parkinson's disease. 134
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 133
Clinical aspects and management of levodopa-induced dyskinesia. 133
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 133
Early detection of substantia nigra changes in Parkinson's disease: a magnetization transfer ratio (MTR) study 132
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 132
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 132
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 132
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 132
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 131
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 130
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 130
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 129
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 129
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. 129
Cerebrospinal fluid biomarkers in Parkinson disease. 128
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 128
Dural arteriovenous fistulas and headache features: an observational study 128
Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. 127
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 127
Acute dystonia induced by the combination of midodrine and perphenazine. 126
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 126
Local synthesis of sex neurosteroids drives the induction of LTP or LTD in the CA1 hippocampal region of male rats 126
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 126
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 126
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 126
Occipital arteriovenous malformations andmigraine. 125
Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer's disease progression 125
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 125
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 125
Phyto-oestrogens in the prophylaxis of menstrual migraine. 124
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 124
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 124
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 124
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 124
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation. 123
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons. 123
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. 123
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 123
Plasticity and repair in the post-ischemic brain 123
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 123
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms. 122
Cell-type specificity of mGluR activation in striatal neuronal subtypes. 122
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. 122
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 122
Diagnostic accuracy of Parkinson disease by Support Vector Machine (SVM) analysis of 123I-FP-CIT brain SPECT data: implications of putaminal findings and age 122
Bidirectional Synaptic Plasticity Is Driven by Sex Neurosteroids Targeting Estrogen and Androgen Receptors in Hippocampal CA1 Pyramidal Neurons 122
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 121
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 121
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 121
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 121
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum. 120
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 120
Modulation of gene expression following long-term synaptic depression in the striatum. 119
Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms 119
Deficits of glutamate transmission in the striatum of experimental hemiballism. 118
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 118
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 118
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 117
Skin biopsy: a new diagnostic tool for autonomic dysfunctions in Parkinson's disease? 117
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. 117
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 117
Migraine with aura in the locker room: three case reports. 117
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 117
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 117
Amyloid-β: a potential link between epilepsy and cognitive decline 117
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 116
Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial. 116
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 116
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 116
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 116
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. 115
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 115
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits. 115
Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache 115
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 115
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects. 114
Totale 13.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 224.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 224.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.451 0 0 0 257 135 55 55 1.426 88 162 475 798
2022/20237.804 619 1.432 157 639 586 979 10 314 2.704 20 257 87
2023/20242.712 166 310 154 59 31 18 433 134 361 92 448 506
2024/20256.587 114 669 226 270 813 325 311 568 1.343 432 932 584
2025/202614.689 1.074 1.083 877 2.231 1.893 1.278 2.294 741 1.612 1.077 315 214
2026/20274.366 355 525 932 2.554 0 0 0 0 0 0 0 0
Totale 49.568